Elite Pharmaceuticals(ELTP): The Hidden Low Cap Gem at 8.8 Cents

Market Cycles can be one hell of a thing.

Elite has been beaten up so badly over the years but has seen revenues rise by 88% during it's last earning call.

These pharmaceuticals companies are always one drug away from hitting jackpot and this is worth a go.